OdnosnoIbudilast?
- Japan. The medicine was approved in Japan in May 1989.
- USA. In 2016, the medicine was approved by the US FDA (link to Ibudalist medicine approval).
- EU. in 2017 in the EU (EMA, the link is available here), as an orphan medicine for the treatment of ALS.
Ketas-MN-166